Spine

Benvenue Medical Signs Group Purchasing Agreement with Novation for Kiva® VCF Treatment System

SANTA CLARA, Calif.–(BUSINESS WIRE)–Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that it has signed a group purchasing agreement for the Kiva® VCF Treatment System with Novation, the leading health care services company. The three-year contract became effective March 1, paving the way to offer the Kiva System through the Novation portfolio to the more than 100,000 members and affiliates of VHA Inc., UHC, Children’s Hospital Association and Provista served by Novation.

The Kiva System was selected through the Novation Innovative Technology program, which is designed to ensure that members have access to innovative health care technology. The rigorous process includes review by a clinical member council or task force to determine whether the technology represents incremental advantage for members. The Kiva System is the first clinically proven new approach to the treatment of vertebral compression fractures (VCFs) in over a decade.

“We are committed to providing the health care facilities we serve new technologies that are clinically validated and cost-effective,” said Olya Carter, RN and Senior Clinical Manager at Novation. “The decision to offer the Kiva System was based on compelling treatment effectiveness data from multiple clinical studies.”

READ MORE HERE

Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

2 Comments

  1. The Kiva system is a novel and forward thinking solution to VCF and the newly augmented Benvenue sales and marketing team will help take this product line and innovative company to the next level of success.

  2. Thanks for the comment James! I agree, I think Benvenue is one of the most exciting spine companies out there and they have taken a thoughtful and fresh approach to the market. It’ll be fun to see if the exit through IPO or if a strategic tries to pick them up before they get there.

Leave a Reply

Your email address will not be published. Required fields are marked *

Close